Your browser doesn't support javascript.
loading
Predictors of responses to immune checkpoint blockade in advanced melanoma.
Jacquelot, N; Roberti, M P; Enot, D P; Rusakiewicz, S; Ternès, N; Jegou, S; Woods, D M; Sodré, A L; Hansen, M; Meirow, Y; Sade-Feldman, M; Burra, A; Kwek, S S; Flament, C; Messaoudene, M; Duong, C P M; Chen, L; Kwon, B S; Anderson, A C; Kuchroo, V K; Weide, B; Aubin, F; Borg, C; Dalle, S; Beatrix, O; Ayyoub, M; Balme, B; Tomasic, G; Di Giacomo, A M; Maio, M; Schadendorf, D; Melero, I; Dréno, B; Khammari, A; Dummer, R; Levesque, M; Koguchi, Y; Fong, L; Lotem, M; Baniyash, M; Schmidt, H; Svane, I M; Kroemer, G; Marabelle, A; Michiels, S; Cavalcanti, A; Smyth, M J; Weber, J S; Eggermont, A M; Zitvogel, L.
Afiliação
  • Jacquelot N; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Roberti MP; University Paris-Saclay, Kremlin Bicêtre, 94 276, France.
  • Enot DP; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Rusakiewicz S; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Ternès N; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Jegou S; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Woods DM; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Sodré AL; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Hansen M; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Meirow Y; CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Sade-Feldman M; University Paris-Saclay, Kremlin Bicêtre, 94 276, France.
  • Burra A; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Kwek SS; Gustave Roussy, Université Paris-Saclay, Service de Biostatistique et d'Epidémiologie, Villejuif, F-94805, France.
  • Flament C; Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, 75005, France.
  • Messaoudene M; Laura & Isaac Perlmutter Cancer Center, New York University Medical Center, New York, NY, 10016, USA.
  • Duong CPM; Laura & Isaac Perlmutter Cancer Center, New York University Medical Center, New York, NY, 10016, USA.
  • Chen L; Center for Cancer Immune Therapy, Department of Hematology and Oncology, Copenhagen University Hospital, Herlev, DK-2730, Denmark.
  • Kwon BS; The Lautenberg Center for General and Tumor Immunology, BioMedical Research institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, 91120, Israel.
  • Anderson AC; The Lautenberg Center for General and Tumor Immunology, BioMedical Research institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, 91120, Israel.
  • Kuchroo VK; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA.
  • Weide B; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, 94143, USA.
  • Aubin F; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Borg C; University Paris-Saclay, Kremlin Bicêtre, 94 276, France.
  • Dalle S; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Beatrix O; CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Ayyoub M; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Balme B; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Tomasic G; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Di Giacomo AM; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Maio M; Department of Immunobiology, Yale School of Medicine, 10 Amistad Street, New Haven, CT, 06519, USA.
  • Schadendorf D; Eutilex, Suite# 1401 Daeryung Technotown 17 Gasan Digital 1-ro 25, Geumcheon-gu, Seoul, 08594, Korea.
  • Melero I; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA, 70112, USA.
  • Dréno B; Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Khammari A; Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Dummer R; Department of Dermatology, University Medical Center Tübingen, Tübingen, 72076, Germany.
  • Levesque M; Université de Franche Comté, EA3181, SFR4234, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, 25000, France.
  • Koguchi Y; Department of Medical Oncology, University Hospital of Besancon, 3 Boulevard Alexander Fleming, Besancon, F-25030, France.
  • Fong L; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, 25030, France.
  • Lotem M; INSERM U1098, University of Franche-Comté, Besançon, 25020, France.
  • Baniyash M; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, 69000, France.
  • Schmidt H; Centre de Recherche en Cancérologie de Lyon, Lyon, 69000, France.
  • Svane IM; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, 69000, France.
  • Kroemer G; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Marabelle A; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Michiels S; Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, 69000, France.
  • Cavalcanti A; Department of Pathology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Lyon, 69000, France.
  • Smyth MJ; Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Weber JS; Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, 94800, France.
  • Eggermont AM; Medical Oncology and Immunotherapy Division, University Hospital of Siena, Viale Bracci, 14, Siena, 53100, Italy.
  • Zitvogel L; Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Instituto Toscano Tumori, Siena, 53100, Italy.
Nat Commun ; 8(1): 592, 2017 09 19.
Article em En | MEDLINE | ID: mdl-28928380
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Ano de publicação: 2017 Tipo de documento: Article